Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-Center, Randomized, Open-Label Study Comparing Bioavailability When Preservative-free Makena (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Next Previous
X
Search
Trial Profile

A Multi-Center, Randomized, Open-Label Study Comparing Bioavailability When Preservative-free Makena (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hydroxyprogesterone (Primary) ; Hydroxyprogesterone
  • Indications Preterm labour
  • Focus Pharmacokinetics; Registrational
  • Sponsors AMAG Pharmaceuticals

    • Most Recent Events

    • 27 Nov 2017 Primary endpoint (Comparison of the maximum plasma concentration (Cmax)) has not been met as per the results published in the Clinical Therapeutics.
    • 27 Nov 2017 Primary endpoint (Comparison of areas under the curve (AUC) to the last time with a concentration LLOQ [AUC0-t] and to infinity [AUCinf])has been met as per the results published in the Clinical Therapeutics.
    • 27 Nov 2017 Results assessing bioavailability of hydroxyprogesterone caproate administered as a subcutaneous injection published in the Clinical Therapeutics

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top